Interne link ProQR Announces Presentations at ECFS on Eluforsen for F508del Cystic Fibrosis and at CFF Research Conference juni 04, 2018 om 11:00 AM UTC
Interne link ProQR Appoints Yi-Tao Yu, Ph.D., to Its Scientific Advisory Board mei 23, 2018 om 11:00 AM UTC
Interne link ProQR Announces Conference Presentations for Axiomer® RNA Editing Technology and QR-313 for DEB april 30, 2018 om 11:00 AM UTC
Interne link ProQR Provides Enrollment Update on QR-110 Clinical Trial and Highlights Ophthalmology Presentations at ARVO april 23, 2018 om 11:00 AM UTC
Interne link ProQR Appoints ADAR Expert Dr. Peter A. Beal to Scientific Advisory Board to Focus on Axiomer® RNA A-to-I Editing Technology april 10, 2018 om 11:00 AM UTC
Interne link ProQR Announces Results for the Fourth Quarter and Full Year 2017 and Provides Business Update februari 28, 2018 om 12:00 PM UTC
Interne link ProQR Supports Rare Disease Day 2018 and Honors Henri A. Termeer februari 27, 2018 om 12:00 PM UTC
Interne link Foundation Fighting Blindness will provide up to $7.5 million in funding to develop ProQR’s candidate QR-421a for Usher syndrome type 2A februari 12, 2018 om 12:00 PM UTC
Interne link ProQR to Present at Upcoming Scientific Meeting and Investor Conference februari 06, 2018 om 12:00 PM UTC
Interne link ProQR and Galapagos Announce Research Collaboration on Fibrosis Targets Using ProQR’s Axiomer® technology januari 08, 2018 om 12:00 PM UTC
Interne link ProQR Announces that QR-010 Meets the Primary Endpoint in a Proof of Concept Study of Homozygous F508del Cystic Fibrosis Patients oktober 27, 2016 om 11:00 AM UTC
Interne link ProQR Announces Clinical Data Presentations and Investor & Analyst Event at NACFC september 27, 2016 om 11:00 AM UTC
Interne link ProQR to Present at Scientific and Investor Conferences in September september 06, 2016 om 11:00 AM UTC
Interne link ProQR Announces Results for the Second Quarter of 2016 augustus 17, 2016 om 11:00 AM UTC
Interne link ProQR Receives Fast Track Designation from FDA for QR-010 for Cystic Fibrosis juli 19, 2016 om 11:00 AM UTC
Interne link ProQR to Release Topline Data from Proof of Concept Study of QR-010 in Cystic Fibrosis Patients at NACFC juni 21, 2016 om 01:00 PM UTC
Interne link ProQR’s Drug Candidate QR-110 for Leber’s Congenital Amaurosis Type 10 Receives EMA and FDA Orphan Drug Designation juni 01, 2016 om 11:00 AM UTC
Interne link ProQR Announces Presentations at the European CF Conference and the JMP Life Science Conference juni 01, 2016 om 11:00 AM UTC
Interne link ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-110 for LCA10 at the 2016 ARVO Annual Meeting april 25, 2016 om 08:00 PM UTC